%PDF-1.4
%
54 0 obj
<>
endobj
51 0 obj
<>
endobj
98 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-03-02T09:27:37Z
2024-03-29T07:18:23-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T07:18:23-07:00
application/pdf
Heather
2003-865.april suppl 70
uuid:351ad131-1dd2-11b2-0a00-170a271d5700
uuid:351ad134-1dd2-11b2-0a00-bf0000000000
endstream
endobj
40 0 obj
<>
endobj
41 0 obj
<>
endobj
55 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 28 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
19 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
22 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
112 0 obj
[116 0 R]
endobj
113 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.8 g
/T1_0 18 Tf
0.6114 0.7912 -0.7912 0.6114 35.383 35.2215 Tm
(Personal, non-commercial use only. The Journal of Rheumatology. Copyrigh\
t \251 2004. All rights reserved.)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc -0.03239 Tw 10 0 0 10 54 713.1616 Tm
[(approach to OA)-162.8 (is cartilage transplantation or the like I think)]TJ
0.0006 Tw 0 -1.2 TD
(we will go the same direction. I think there is a third option,)Tj
0.1232 Tw T*
[(which I believe is the option we should be going for: )17.8 (W)79.9 (e)]TJ
-0.0085 Tw T*
(should be looking for low tech, inexpensive, simple ways of)Tj
0.09351 Tw T*
(reducing the burden of illness with respect to pain, limita-)Tj
0.0009 Tw T*
(tion of activities, and participation in life by older people. If)Tj
-0.0244 Tw T*
(we\325re going to progress in this field, I believe we must make)Tj
0.02499 Tw T*
(these paradigm shifts.)Tj
/T1_2 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES)Tj
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 61 595.1616 Tm
[(1.)-875.1 (Radin EL. )17.7 (Who gets OA)-220.2 (and why? J Rheumatol 2004;31 Suppl 70:)]TJ
0 Tc 0 Tw 1.675 -1.25 Td
(10-15.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(2.)-875.1 (Brandt KD, Heilman DK, Slemenda C, et al. Quadriceps strength in)]TJ
1.675 -1.25 Td
(women with radiographically progressive osteoarthritis of the knee)Tj
0 -1.25 TD
(and those with stable radiographic changes. J Rheumatol)Tj
0 Tc 0 Tw T*
(1999;26:2431-7.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(3.)-875.1 (Felson DT)73.9 (. Obesity)64.9 (, vocational and avocational overload of the)]TJ
1.675 -1.25 Td
(joint as risk factors for osteoarthritis. J Rheumatol 2004;31 Suppl)Tj
0 Tw T*
(70:2-5. )Tj
-0.0005 Tc 0.02541 Tw -1.675 -1.25 Td
[(4.)-875.5 (Hochber)17.3 (g MC. Do risk factors for incident hip OA)-220.6 (dif)17.3 (fer from those)]TJ
-0.0051 Tc 0.02499 Tw 1.675 -1.25 Td
(for progression of hip OA? J Rheumatol 2004;31 Suppl 70:6-9.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(5.)-875.1 (Creamer P)110.7 (, Lethbridge-Cejku M, Hochber)17.7 (g MC. Determinant of)]TJ
1.675 -1.25 Td
[(pain severity in knee osteoarthritis: ef)17.7 (fect of demographic and)]TJ
T*
(psychosocial variables using 3 pain measures. J Rheumatol)Tj
0 Tc 0 Tw T*
(1999;26:1785-92.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(6.)-875.1 (McAlindon )17.7 (TE, Cooper C, Kirwan JR, Dieppe P)91.7 (A. Determinants of)]TJ
1.675 -1.25 Td
[(disability in osteoarthritis of the knee. )54.8 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(1993;52:258-62.)Tj
0.0249 Tw 31.325 36.171 Td
[(7.)-875 (Dieppe P)91.8 (A)0.1 (, Cushnaghan J, Shepstone L. )17.7 (The Bristol \324OA500\325)]TJ
-0.00011 Tc 1.675 -1.25 Td
(study: progression of osteoarthritis \(OA\) over 3 years and the )Tj
T*
(relationship between clinical and radiographic changes at the knee)Tj
T*
(joint. Osteoarthritis Cartilage 1997;5:87-97.)Tj
-1.675 -1.25 Td
[(8.)-875.1 (Dieppe P)110.7 (,)-0.1 ( Cushnaghan J, )17.7 (T)35 (ucker M, Browning S, Shepstone L. )17.7 (The)]TJ
1.675 -1.25 Td
(Bristol \324OA500 study\325: progression and impact of the disease after\
)Tj
T*
(8 years. Osteoarthritis Cartilage 2000;8:63-8.)Tj
-1.675 -1.25 Td
[(9.)-875.1 (Sharma L. )17.7 (The role of proprioceptive deficits, ligamentous laxity)64.8 (,)]TJ
1.675 -1.25 Td
(and malalignment in development and progression of knee)Tj
T*
(osteoarthritis. J Rheumatol 2004;31 Suppl 70:87-92)Tj
-2.175 -1.25 Td
[(10.)-875.1 (T)69.9 (allon D, Chard JA, Dieppe P)91.7 (A. Exploring the priorities of patients)]TJ
2.175 -1.25 Td
[(with osteoarthritis of the knee. )54.8 (Arthritis Care Res 2000;13:312-9.)]TJ
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (W)79.9 (orld Health Or)17.7 (ganization. International classification of )]TJ
2.1381 -1.25 Td
[(functioning, disability)64.8 (, and health [Internet]. Cited Dec. 15, 2003.)]TJ
T*
[(A)73.9 (vailable from: http://www)64.8 (.who.int/classification/icf )]TJ
-2.175 -1.25 Td
[(12.)-875.1 (A)91.8 (yis S, Gooberman-Hill R, Ebrahim S. Long-standing and limiting)]TJ
2.175 -1.25 Td
(long-standing illness in older people: associations with chronic)Tj
T*
[(diseases, psychosocial and environmental factors. )54.8 (Age )54.8 (Ageing)]TJ
0 Tc 0 Tw T*
(2003;32:265-72.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(13.)-875.1 (Sanders C, Donovan J, Dieppe P)110.7 (.)-0.1 ( )17.7 (The significance and )]TJ
2.175 -1.25 Td
(consequences of having painful and disabled joints in older age: )Tj
T*
(co-existing accounts of normal and disrupted biographies.)Tj
T*
(Sociology Health Illness 2002;24:227-53.)Tj
-2.175 -1.25 Td
[(14.)-875.1 (W)79.9 (oolhead GM, Donovan JL, Chard JA, Dieppe P)91.7 (A. )17.7 (Who should)]TJ
2.175 -1.25 Td
(have priority for a knee joint replacement? Rheumatology)Tj
0 Tc 0 Tw T*
(2002;41:390-4.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(15.)-875.1 (Moynihan R, Smith R. )17.7 (T)69.9 (oo much medicine? )54.8 (Almost certainly)]TJ
2.175 -1.25 Td
([editorial]. BMJ 2002;324:859-60.)Tj
-2.175 -1.25 Td
[(16.)-875.1 (Illich I. Limits to medicine. London: Penguin Books; 1977.)]TJ
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_3 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(Dieppe: T)91.7 (ar)36.8 (gets for OA)-257.3 (therapy)]TJ
0 Tc 0 Tw 61.9375 -0.0313 Td
(53)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.08 396.48 -10.83 re
f*
0.5 w
109.22 59.08 396.48 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_4 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_5 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
34 0 obj
<>stream
8;Z\7d11gP%,:g^i-siA_V,G1d-)dBX=p"U7_^V&U`HY
K0to67DT#NlTJiKD[6K8TB6g+g^c5n(/65#@BjVi.d>9D`m$U\o'$G3mr&9(k/7\B
2W_r-18:+9_6dVISEP#g+XgJamj2>\P1/KDZcm1H3O!oD]C_(//2@Ro%2eqBg,S4p
)2I3U=^nO=mP1)1G(%a@ZE;3=?[T\jMg:4X
'-"C[#GC952b,_Phi7N"7sm\J[j"d2hOK*I_20=abrq1[,SGr%,*>DA&o5R24;)0:
nL8VRF#C^%Iu)DNC'oDJ~>
endstream
endobj
38 0 obj
[/Indexed/DeviceRGB 255 37 0 R]
endobj
37 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
80 0 obj
<>
endobj
57 0 obj
<>
endobj
25 0 obj
<>
endobj
60 0 obj
<>
endobj
89 0 obj
<>
endobj
103 0 obj
<>
endobj
59 0 obj
<>
endobj
68 0 obj
<>stream
HtTyPSpoQQZQX֍EED,RQB @ĐlDdA.hZb]n>i0S۞?99s~w>stpwi~H,-(M~_0fLw`c3xIPɅb`cn4E"=II^@* icH&ȥBqt@G(Jȕ)BZAlr"T q2Q(V*v1~3f<ccK lN0>F*,ۋ=
qXP
+ev,u|I${
"4q}W?7oBϩe2'yҼI&k'?wNtr{uvwѯV]pG ߲n!3
=:uybQFeLY:KOeGaFnT#%VEkڪJ$
ădڄ߇,cFG&Ek@nhyvјִ>ղK;N?~/TG:=x] vrNP]EŊZlx; 3ն6ԡB"]lj*5Ir|$YxJhۍ%U%|NC~ 3ianaW
}CSnFDqf89%ƲD!aېsWh&(2u
' 4ۓTsdy"MXٷ}e(kwdJFnRd[/SM-OzJ_4y"b+Vz6鬜d]w!@W3x_cVXp:ceȄ\SIZ3EZS/@\r;SڊOgjbKKa9~pBKQk_X!b?ukݗ$m)F_D]K4P:H5H<
ȃBˑrL zt˝S/nv%NyAtfmt"BR:ݾ]-Cvc&v1qnb1.6oz'S
#%fSXNGsFqv{-ޛ~?yKId!P.h3䌰6VuQj>ʔ
`
pO;pZzVr#ml.+(n(1xz#VD\3Zs&gؒ 䀺.oP0]x[+6E2W+K6X?@T4@s6(b2m~eTR,Grzkf#Z 3vO-p썰ޫ&LvB4av6\z6#^cBi撺rLZV,{"'WuclvN=cJ
VC^턅BAFeJvD&[U*df-OIn_qeo*"nm^>*@T@FU?=t=\+@k%f7J"(4QQDS7ԙ$VtL[]juTU# ]n!&$!\L INNPQuʴE/w/ܺk봿ϙ _
[z%iI=zf0j }S@:μ
␛x7KX61P ;5 XHgLEܚRϒǤK 氱O^CeL{liI&
=cu씝ȓSqʃndn7\$I5<Ji|U
8QˑW"0\-0} $]R䑒LyR b*! r D.]Ѷ806`ȀA=gA"[ޠh ~pQmA۟_HC317 g}®xZ
S@]g}=N@;R?ܼV23.Y
S:|i K}83fwyl0}\
-,C*cI1l-+KjHPF~(~`